- Home
- RLYB
RLYB
Rallybio Corporation
as of 03-03-2026 3:55pm EST
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | NEW HAVEN |
| Market Cap: | 28.7M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 201.4K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.07 | EPS Growth: | 27.72 |
| 52 Week Low/High: | $0.22 - $11.20 | Next Earning Date: | N/A |
| Revenue: | $600,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 17.61% | Revenue Growth (next year): | N/A |
| P/E Ratio: | -157.14 | Index: | N/A |
| Free Cash Flow: | -49282000.0 | FCF Growth: | N/A |
AI-Powered RLYB Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Rallybio Corporation (RLYB)
Chief Financial Officer
Avg Cost/Share
$5.06
Shares
789
Total Value
$3,992.34
Owned After
4,115
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Lieber Jonathan I | RLYB | Chief Financial Officer | Feb 23, 2026 | Sell | $5.06 | 789 | $3,992.34 | 4,115 |
Compare RLYB vs Leading Stocks
See how RLYB stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "RLYB Rallybio Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.